secwatch.observer — SEC 8-K summary
======================================

Issuer:     Trevi Therapeutics, Inc. (TRVI)
CIK:        0001563880
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0001564590-22-024091
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Trevi Therapeutics shareholders elect Good and VanLent, ratify EY as auditor
----------------------------------------------------------------------------

- Jennifer Good received 21,768,228 votes for and 178,450 withheld; broker non-votes 9,566,404.
- Anne VanLent received 21,763,978 votes for and 182,700 withheld; broker non-votes 9,566,404.
- Ratification of Ernst & Young as auditor: 31,324,562 for, 8,689 against, 179,831 abstain.
- Annual meeting held June 23, 2022; no other proposals were voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563880/000156459022024091/0001564590-22-024091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563880/000156459022024091/trvi-8k_20220623.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-024091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer